Inhibikase Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.05

+0.00 (+0.00%)

As of Sep 29, 2:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,266.3% upside

Low Target $19.41

Average Target $28.01

High Target $39.32

Current Price $2.05

Current
$2.05

Target
$28.01

$19.41 $28.01 avg $39.32

Scenario Analysis

Bear Case

$19.41

846.8%

Low target

Base Case

$28.01

+1,266.3%

Avg target

Bull Case

$39.32

+1,818.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.61

-21.5% from high

52-Week Low

$1.33

+54.1% from low

Target vs 52W High

$28.01

+973.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%